Expanded indications for stroke thrombolysis—what next?
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Clinical Neurology
Link
http://www.nature.com/articles/nrneurol.2012.151.pdf
Reference10 articles.
1. Donnan, G. A., Fisher, M., Macleod, M. & Davis, S. M. Stroke. Lancet 371, 1612–1623 (2008).
2. Davis, S. M. & Donnan, G. A. Clinical practice. Secondary prevention after ischemic stroke or transient ischemic attack. N. Engl. J. Med. 366, 1914–1922 (2012).
3. Whiteley, W., Lindley, R., Wardlaw, J. & Sandercock, P. Third international stroke trial. Int. J. Stroke 1, 172–176 (2006).
4. IST-3 collaborative group. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 379, 2352–2363 (2012).
5. Sandercock, P., Lindley, R., Wardlaw, J., Whiteley, W. & Murray, G. Statistical analysis plan for the third international stroke trial (IST-3); part of a 'thread' of reports of the trial. Int. J. Stroke 7, 186–187 (2012).
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The dual roles of autophagy and the GPCRs-mediating autophagy signaling pathway after cerebral ischemic stroke;Molecular Brain;2022-02-02
2. Review Cerebral Ischemic Tolerance and Preconditioning: Methods, Mechanisms, Clinical Applications, and Challenges;Frontiers in Neurology;2020-09-18
3. Effects of thrombolysis within 6 hours on acute cerebral infarction in an improved rat embolic middle cerebral artery occlusion model for ischaemic stroke;Journal of Cellular and Molecular Medicine;2019-01-29
4. The development of biological therapies for neurological diseases: moving on from previous failures;Expert Opinion on Drug Discovery;2018-02-07
5. Therapeutic Antibodies in Stroke;Translational Stroke Research;2013-08-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3